Cosmos & Space
STAT Plus Reports on Major Executive Leadership Changes
Dr. Anya Sharma, former head of R&D at BioGen Corp, a major pharmaceutical player, abruptly left her post to become CEO of GenePath, a gene-editing startup that recently secured $150M in Series B fund
David Grossman·June 13, 2026
